Details for New Drug Application (NDA): 016727
✉ Email this page to a colleague
NDA 016727 describes PROLIXIN DECANOATE, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the PROLIXIN DECANOATE profile page.
The generic ingredient in PROLIXIN DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
The generic ingredient in PROLIXIN DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
Summary for 016727
| Tradename: | PROLIXIN DECANOATE |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | fluphenazine decanoate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
